| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/18/2013 | US20130184231 Organ arrest, protection and preservation |
| 07/18/2013 | US20130184218 Targeted Osmotic Lysis of Cancer Cells |
| 07/18/2013 | US20130184217 Targeting micrornas for the treatment of fibrosis |
| 07/18/2013 | US20130184213 Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders |
| 07/18/2013 | US20130184206 Selective androgen receptor modulators (SARMs) and uses thereof |
| 07/18/2013 | US20130184205 Antitumor combinations containing a vegf-inhibiting agent and 5fu or a derivative thereof |
| 07/18/2013 | US20130184204 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| 07/18/2013 | US20130184202 Peptide Inhibitors and Methods of Use Thereof |
| 07/18/2013 | US20130183395 Compositions comprising botanicals, including the use and method of use thereof |
| 07/18/2013 | US20130183388 Novel IDO Inhibitors and Methods of Use Thereof |
| 07/18/2013 | US20130183387 Methods for treating pustular conditions of the skin |
| 07/18/2013 | US20130183383 Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same |
| 07/18/2013 | US20130183381 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor |
| 07/18/2013 | US20130183378 CD133 Epitopes |
| 07/18/2013 | US20130183369 Means of inducing cellular exocytosis and uses thereof |
| 07/18/2013 | US20130183368 P97-antibody conjugates and methods of use |
| 07/18/2013 | US20130183354 Compositions and methods for cancer treatment using targeted carbon nanotubes |
| 07/18/2013 | US20130183351 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products |
| 07/18/2013 | US20130183325 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations |
| 07/18/2013 | US20130183321 Gitr binding molecules and uses therefor |
| 07/18/2013 | US20130183319 Fgfr4 antibodies |
| 07/18/2013 | US20130183316 Agonistic antibody to cd27 |
| 07/18/2013 | US20130183315 Antibodies that bind to OX40 and their uses |
| 07/18/2013 | US20130183313 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 07/18/2013 | US20130183309 Fragments, Mutants and Chimeric Fusion Proteins of Leptin For Treating Alzheimer's Disease |
| 07/18/2013 | US20130183304 Neuropilin as a biomarker for bevacizumab combination therapies |
| 07/18/2013 | US20130183298 Methods of Treating Hepatitis With Anti-TNF alpha Antibodies |
| 07/18/2013 | US20130183297 Method of treating cancers and a pharmaceutical composition that may be used in practicing said method |
| 07/18/2013 | US20130183293 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue , and/or fever |
| 07/18/2013 | US20130183290 Combination therapy of an afucosylated cd20 antibody with an anti-vegf antibody |
| 07/18/2013 | US20130183288 Non-fucosylated antibodies |
| 07/18/2013 | US20130183285 Methods for accelerating the healing of connective tissues injuries and disorders |
| 07/18/2013 | US20130183277 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 07/18/2013 | US20130183269 Hepatitis C Virus Inhibitors |
| 07/18/2013 | US20130183268 Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 07/18/2013 | US20130183267 Cyclosporin analogues for preventing or treating hepatitis c infection |
| 07/18/2013 | US20130183266 Compounds and methods for the treatment or prevention of flavivirus infections |
| 07/18/2013 | US20130183265 Mia-2 protein |
| 07/18/2013 | US20130183264 Antagonists of IL-6 to raise albumin and/or lower crp |
| 07/18/2013 | US20130183255 Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same |
| 07/18/2013 | US20130183254 Methods and compositions for promoting hair growth |
| 07/18/2013 | US20130183251 Penetrating pharmaceutical foam |
| 07/18/2013 | US20130183245 Methods of treating cerebral amyloid angiopathy |
| 07/18/2013 | US20130181107 Furnace mount and method of installation |
| 07/18/2013 | CA2860952A1 Fixed dose combination therapy of parkinson's disease |
| 07/17/2013 | EP2615114A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 07/17/2013 | EP2615113A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 07/17/2013 | EP2614860A2 Pharmaceutical composition for the treatment of dry eye |
| 07/17/2013 | EP2614839A2 Method for using BOC/CDO to modulate hedgehog signaling |
| 07/17/2013 | EP2614838A1 Agent for treatment of dry eye characterized by combining p2y² receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y² receptor agonist and hyaluronic acid or salt thereof |
| 07/17/2013 | EP2614813A1 Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent |
| 07/17/2013 | EP2613790A1 Laxative containing polyethylene glycol and electrolytes |
| 07/17/2013 | EP2613780A1 Methods for concomitant treatment of theophylline and febuxostat |
| 07/17/2013 | EP2613774A2 Novel use |
| 07/17/2013 | CN103203027A Methods And Compositions For The Treatment And Prevention Of Aging-associated Conditions |
| 07/17/2013 | CN103203021A Hair pilatory and preparation method thereof |
| 07/17/2013 | CN103203020A Application of statin medicines in preparing medicines used for treating chronic subdural hematoma |
| 07/17/2013 | CN103203010A Pharmaceutical Compositions Comprising Hepatitis C Inhibitor Compounds |
| 07/17/2013 | CN103202845A Pharmaceutical Composition Of A Sodium Channel Blocker And A Selective Serotonin Uptake Inhibitor |
| 07/17/2013 | CN103202813A Method for preparing protein nanoparticles for in vivo delivery of pharmacologically active substances |
| 07/17/2013 | CN102441179B Silicon dioxide base ultrasonic contrast medium/high intensity focused ultrasound (HIFU) synergist and preparation method thereof |
| 07/17/2013 | CN102361638B Transdermal preparation |
| 07/17/2013 | CN102316876B High dosage doramectin formulation |
| 07/17/2013 | CN102210864B Formula of medicament for treating non-infectious ocular inflammations, and inhibiting corneal neovascularization and anti-rejection reaction generated after corneal transplantation |
| 07/17/2013 | CN102206276B Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
| 07/17/2013 | CN102119923B Antibiotic oil-water double suspension type injection emulsion for livestock and preparation method thereof |
| 07/17/2013 | CN101985037B Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance |
| 07/17/2013 | CN101910182B Antitumor agent |
| 07/17/2013 | CN101087593B Colonic purgative composition with soluble binding agent |
| 07/17/2013 | CN101060860B Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
| 07/16/2013 | US8487003 Treatment of cancer by administration of perfluorooctanoic acid |
| 07/16/2013 | US8487001 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/16/2013 | US8486957 Chemotherapeutic for inducing an MSH2-dependent apoptotic pathway |
| 07/16/2013 | US8486923 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 07/16/2013 | US8486908 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 07/16/2013 | US8486698 Inducing differentiation of an isolated marrow stromal cell into a neuronal cell tissue engineering for use in prevention and treatment of nervous system disorders; regenerative medicine; tissue engineering |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
| 07/16/2013 | US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling |
| 07/16/2013 | US8486391 Cancer treatment kits using antibodies to aminophospholipids |
| 07/16/2013 | US8486382 Method for treating cervical cancer |
| 07/16/2013 | CA2673615C Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 07/16/2013 | CA2549115C Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 07/16/2013 | CA2483980C Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 07/16/2013 | CA2480925C Compositions comprising retinoids and nondenatured botanical extracts having trypsin-inhibiting activity for treating skin conditions |
| 07/16/2013 | CA2464656C Spray drying methods and compositions thereof |
| 07/16/2013 | CA2395406C Method for treating inflammation |
| 07/16/2013 | CA2384948C Therapies for chronic renal failure using one or more integrin antagonists |
| 07/16/2013 | CA2358684C Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/16/2013 | CA2330231C Composition and method for modulating dendritic cell-t cell interaction |
| 07/16/2013 | CA2226624C Methods for treatment of allergic asthma |
| 07/11/2013 | WO2013103089A1 Culture method for maintenance and propagation of stem cells by lysophospholipid signal control |
| 07/11/2013 | WO2013102651A1 Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide |
| 07/11/2013 | WO2013059791A3 Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders |
| 07/11/2013 | WO2012061045A3 Methods and compositions for preserving retinal ganglion cells |
| 07/11/2013 | US20130178534 N-Nonanoylvanillylamine as an agent for reducing the appetite, as an agent for imparting a feeling of fullness and as a mood enhancer, and corresponding substance mixtures, orally consumable products and methods |
| 07/11/2013 | US20130178498 Bicyclic heteroaryl inhibitors of pde4 |
| 07/11/2013 | US20130178486 Serine/threonine kinase inhibitors |
| 07/11/2013 | US20130178484 Treatment of gout and hyperuricemia |
| 07/11/2013 | US20130178482 3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl) carbamimidoyl)pyrazine-2-carboxamide |